The U.S. Agency for International Development (USAID) has committed $2.3 million to purchase 4.8 million doses of malaria medication from Swiss Pharma (Swipha).
Trending
- Traditional medicine at the core of Universal Health Coverage – Agency
- JAMB commences accreditation of centres for 2025 UTME
- Nigeria, India partner to revolutionize healthcare delivery
- Kebbi partners Indonesia on embryo transfer, artificial insemination
- Accidents: 3,767 killed, 22,373 others injured in Nigeria – FRSC
- COP29: Ghana, 2 others launch roadmap to drive sustainable construction
- COP29 must unlock funds needed for energy transition – ActionAid
- COP29: Advocates push for global shift away from meat overconsumption
